First experience in the UK of treating women with recurrent urinary tract infections with the bacterial vaccine Uromune®

BJU International

Volumn 121, Issue 2, 2018, Pages 289-292

  Yang, Bob ^a   Foley, Stephen ^a,b  

^a ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^b Reading Urology Partnership   (United Kingdom)

Author keywords

bacterial vaccine; immunomodulation; recurrent UTI

Indexed keywords

BACTERIAL VACCINE; UROMUNE; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; ESCHERICHIA COLI; EXPERIENCE; FEMALE; HUMAN; INFECTION PREVENTION; KLEBSIELLA; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS; RASH; RECURRENT INFECTION; SERRATIA MARCESCENS; UNITED KINGDOM; URINARY TRACT INFECTION; VACCINATION; ADOLESCENT; DRUG ERUPTION; FOLLOW UP; MIDDLE AGED; PROCEDURES; RECURRENT DISEASE; SECONDARY PREVENTION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL VACCINES; DRUG ERUPTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; SECONDARY PREVENTION; UNITED KINGDOM; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 85034949556     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.14067     Document Type: Article

References (12)

1. Albert X, Huertas I, Pereiro II, Sanfelix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004; 3: CD001209
2. World Health Organization. Global Action Plan on antimicrobial resistance, Geneva: World Health Organization, 2015. Available at: http://apps.who.int.iris/bitstream/10665/193736/1/9789241509763_eng.pdf?ua=1. Accessed August 2017
3. Yang B, Foley S, Toozs-Hobson P. Urinary tract infections: current and new preventative options. SM J Clin Med 2016; 2: 1018
4. Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11(4 Suppl): S45–53
5. Beerepoot MA, Geerlings SE, van Haarst EP, van Charante NM, ter Riet G. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol 2013; 190: 1981–9
6. Cuburu N, Kweon MN, Song JH et al. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 2007; 25: 8598–610
7. Lorenzo-Gomez MF, Padilla-Fernandez B, Garcia-Cenador MB et al. Comparison of sublingual therapeutic vaccine with antibiotics for the prophylaxis of recurrent urinary tract infections. Front Cell Infect Microbiol 2015; 5: 50
8. Salvatore S, Leone Roberti Maggiore U, Athanasiou S et al. Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study. Menopause 2015; 22: 845–9
9. Yang B, Foley C, Foley S. MP23-05 Using Femtouch in the treatment of women with recurrent Urinary Tract Infections: First experience in the United Kingdom. J Urol 2017; 197: e294–5
10. Zerbinati N, Serati M, Origoni M et al. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci 2015; 30: 429–36
11. Beerepoot M, Geerlings S. Non-antibiotic prophylaxis for urinary tract infections. Pathogens 2016; 5: pii: E36
12. Wagenlehner FM, Ballarini S, Pilatz A, Weidner W, Lehr L, Naber KG. A randomized, double-blind, parallel-group, multicenter clinical study of Escherichia coli-lyophilized Lysate for the prophylaxis of recurrent uncomplicated urinary tract infections. Urol Int 2015; 95: 167–76